The Gloria Borges WunderGlo Foundation has given $1.1-Million Dollars directly to research funding for the cure of colorectal cancer in only their sixth year as an organization, through 100% grass-roots funding with no major donor or sponsor.
The Wunder Project is a movement that was created by one doctor and one patient. A movement to get every person involved to change the face of cancer. The Gloria Borges WunderGlo Foundation continues this movement on a mission to fund vital research for the cure of colorectal cancer. Contrary to popular belief, it can be cured. The only thing standing in the way between patients and a cure is money, bureaucracy, and politics.
The Wunder Project is creative, forward-thinking, and aggressive. The Wunder Project will not back down until we have raised every last cent of the $250 MILLION DOLLARS NEEDED FOR THE CURE and we will ensure that the process will not be held up by inefficiency, middlemen, or red tape. Yes, finding the cure will be nothing short of miraculous. But this is a miracle that we can achieve and a miracle from which we can all benefit. YOU CAN BE PART OF THAT MIRACLE. EVERY PERSON, EVERY DOLLAR, EVERY DISCUSSION COUNTS. You were born to kick cancer’s ass – join Dr. Heinz-Josef Lenz, our founder, Gloria Borges, and The WunderGlo Foundation in our audacious mission to cure colon cancer. CANCER, YOUR TIME IS UP!
• $1.1 Million Dollars in Grants directed to Dr. Heinz-Josef Lenz at USC-Norris Comprehensive Cancer Center and to Dr. Christina Curtis at Stanford University Medical School. The Stanford grant targets urgent work/understanding the mechanisms of colorectal cancer progression.
• THE WUNDER PROJECT RESEARCH -WunderGlo Foundation Funded Research, credited since 2015, has been published in 17-peer reviewed research papers, including New England Journal of Medicine, Lancet Oncology, Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research and Molecular Cancer Therapeutics.
• The WunderGlo Foundation grants to USC-Norris Comprehensive Cancer Center and established a strategic partnership with Stanford University Medical School. The Stanford grant was directed to Dr. Christina Curtis, who’s important work is focused on understanding and characterizing the genomic determinants and dynamics of metastatic colorectal cancer towards the goal of earlier detection and intervention, as well as improved treatment stratification.
• In 2016, through Wunder Project funding, new biomarker patents have been filed at USC- Norris Comprehensive Cancer Center.